LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 89.57 | 84.90 | 8647 | 7494 | 1.1538 | 1.0447 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 89.57 | 84.90 | 578 | 7494 | 0.0771 | 0.3455 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 89.57 | 84.90 | 5105 | 7494 | 0.6812 | 0.8847 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 91.27 | 84.90 | 1419 | 7420 | 0.1912 | 0.5475 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 91.27 | 84.90 | 8915 | 7420 | 1.2015 | 1.0577 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 91.27 | 84.90 | 147 | 7420 | 0.0198 | 0.0888 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 91.27 | 84.90 | 4973 | 7420 | 0.6702 | 0.8797 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.98 | 84.90 | 1527 | 7257 | 0.2104 | 0.5687 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.98 | 84.90 | 9257 | 7257 | 1.2755 | 1.0773 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.98 | 84.90 | 28 | 7257 | 0.0039 | -0.1587 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 92.98 | 84.90 | 4767 | 7257 | 0.6568 | 0.8732 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 84.90 | 1621 | 7000 | 0.2316 | 0.5894 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 84.90 | 9561 | 7000 | 1.3658 | 1.1004 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 84.90 | 6 | 7000 | 0.0009 | -0.3405 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 94.68 | 84.90 | 4487 | 7000 | 0.6410 | 0.8650 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 523 | 285 | 1.8303 | 1.8247 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 691 | 285 | 2.4183 | 2.3118 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.66 | 84.90 | 645 | 285 | 2.2573 | 2.1840 | MN20160318_Q02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.36 | 84.90 | 637 | 322 | 1.9748 | 1.8476 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.36 | 84.90 | 793 | 322 | 2.4584 | 2.1906 | MN20160318_Q02 | K07 |